In univariate analysis, high expression of PRDM1 in tumor samples correlates with poor prognosis in LAML (p = 0.001), LGG (p < 0.001), PAAD (p = 0.008), UVM (p < 0.001) (Figure 2A); while high expression of PRDM1 correlates with favorable prognosis in KIRC (p = 0.002), SKCM (p < 0.001) and THCA (p = 0.033). This evidence concerns the gene PRDM1 and neoplasm.